It is administered as a subcutaneous injection once weekly, with available doses of 0.75 mg, 1.5 mg, 3 mg, and 4.5 mg (Table 1)
GLP-1 receptor agonists should not be used in combination with DPP-4 inhibitors (such as sitagliptin), as both act on the incretin system
Notably, the Frias phase 2 trial in type 2 diabetes reported no level 2 or level 3 hypoglycaemia in any arm, but those participants were on metformin with or without an SGLT2 inhibitor not insulin [13]
Find out in our CL Answer about foods, supplements, and kidney stone risk
[01:09-02:46] And then the FDA stepped in and said, absolutely not
Supplementary information Glossary Ferroptosis A regulated, iron-dependent form of cell death driven by uncontrolled lipid peroxidation, arising from failure of the glutathione-dependent antioxidant system, and genetically and biochemically distinct from apoptosis and other programmed death pathways